
San Carlos-based Range Biotechnologies develops proteomics tools for personalized health insights and disease study.
Founded in San Carlos, California, Range Biotechnologies is dedicated to advancing personalized health through translational proteomics. Their mission is to provide precise measurement tools for analyzing multiple proteins across numerous samples, thereby offering critical insights into disease mechanisms and their progression. The company focuses on developing cutting-edge proteomics tools that enable researchers and healthcare professionals to better understand and combat various diseases.
Range Biotechnologies has attracted notable strategic partners and investors, contributing to its rapid growth and innovation in the field. The company's key achievements include the successful development of advanced proteomics technologies that have significantly impacted personalized medicine and disease research. By enabling more accurate and comprehensive protein analysis, Range Biotechnologies is making substantial contributions to the understanding and treatment of complex health conditions.

Glyphic Biotechnologies
glyphic.bio

Encodia
encodia.com

Proteios Technology
proteios.com

Seer
seer.bio

PrognomiQ
prognomiq.com

CasTag Biosciences

Panome Bio
panomebio.com

Correlia Biosystems

Transomic Technologies

Applied Proteomics

RootPath Genomics
rootpath.com

ProFound Therapeutics
profoundtx.com

GMJ Technologies
gmjtechs.com

Alamar Biosciences
alamarbio.com

Element Biosciences
Companies similar to Range Biotechnologies include Glyphic Biotechnologies, Encodia, Proteios Technology and Seer.
Range Biotechnologies was founded in 2021.
Range Biotechnologies' headquarters is located in San Carlos, CA, US.
Range Biotechnologies' most recent funding round was for $5.2M (USD) in June 2023.
As of Jun 12, 2023, Range Biotechnologies has raised a total of $5.2M (USD).
Range Biotechnologies has 6 employees as of Feb 4, 2024.